324 related articles for article (PubMed ID: 29178719)
1. Quantitation of endotoxin and lipoteichoic acid virulence using toll receptor reporter gene.
Huggins T; Haught JC; Xie S; Tansky CS; Klukowska M; Miner MC; White DJ
Am J Dent; 2016 Dec; 29(6):321-327. PubMed ID: 29178719
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide and Lipoteichoic Acid Virulence Deactivation by Stannous Fluoride.
Haught C; Xie S; Circello B; Tansky CS; Khambe D; Klukowska M; Huggins T; White DJ
J Clin Dent; 2016 Sep; 27(3):84-89. PubMed ID: 28390203
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2.
Han SH; Kim JH; Martin M; Michalek SM; Nahm MH
Infect Immun; 2003 Oct; 71(10):5541-8. PubMed ID: 14500472
[TBL] [Abstract][Full Text] [Related]
4. Lipoteichoic acid of Streptococcus mutans interacts with Toll-like receptor 2 through the lipid moiety for induction of inflammatory mediators in murine macrophages.
Hong SW; Baik JE; Kang SS; Yun CH; Seo DG; Han SH
Mol Immunol; 2014 Feb; 57(2):284-91. PubMed ID: 24216318
[TBL] [Abstract][Full Text] [Related]
5. Clinical Effects of Stabilized Stannous Fluoride Dentifrice in Reducing Plaque Microbial Virulence I: Microbiological and Receptor Cell Findings.
Klukowska M; Haught JC; Xie S; Circello B; Tansky CS; Khambe D; Huggins T; White DJ
J Clin Dent; 2017 Jun; 28(2):16-26. PubMed ID: 28657701
[TBL] [Abstract][Full Text] [Related]
6. Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans.
Hoogerwerf JJ; de Vos AF; Bresser P; van der Zee JS; Pater JM; de Boer A; Tanck M; Lundell DL; Her-Jenh C; Draing C; von Aulock S; van der Poll T
Am J Respir Crit Care Med; 2008 Jul; 178(1):34-41. PubMed ID: 18403723
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic nitric oxide-stimulatory activity of lipoteichoic acids from different Gram-positive bacteria.
Zídek Z; Farghali H; Kmoníčková E
Nitric Oxide; 2010 Dec; 23(4):300-10. PubMed ID: 20850558
[TBL] [Abstract][Full Text] [Related]
8. Regional modulation of toll-like receptor signaling pathway genes in acute epididymitis in mice.
Andrade AD; Almeida PGC; Mariani NAP; Santos NCM; Camargo IA; Martini PV; Kushima H; Ai D; Avellar MCW; Meinhardt A; Pleuger C; Silva EJR
Andrology; 2024 Jul; 12(5):1024-1037. PubMed ID: 38497291
[TBL] [Abstract][Full Text] [Related]
9. Lipoteichoic Acid Inhibits Lipopolysaccharide-Induced TLR4 Signaling by Forming an Inactive TLR4/MD-2 Complex Dimer.
Watanabe S; Zenke K; Muroi M
J Immunol; 2023 May; 210(9):1386-1395. PubMed ID: 36897262
[TBL] [Abstract][Full Text] [Related]
10. Chemical synthesis of bacterial lipoteichoic acids: an insight on its biological significance.
Schmidt RR; Pedersen CM; Qiao Y; Zähringer U
Org Biomol Chem; 2011 Apr; 9(7):2040-52. PubMed ID: 21327200
[TBL] [Abstract][Full Text] [Related]
11. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2.
Schwandner R; Dziarski R; Wesche H; Rothe M; Kirschning CJ
J Biol Chem; 1999 Jun; 274(25):17406-9. PubMed ID: 10364168
[TBL] [Abstract][Full Text] [Related]
12. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.
Dziarski R; Wang Q; Miyake K; Kirschning CJ; Gupta D
J Immunol; 2001 Feb; 166(3):1938-44. PubMed ID: 11160242
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide and lipoteichoic acid binding by antimicrobials used in oral care formulations.
Haught JC; Xie S; Circello B; Tansky CS; Khambe D; Sun Y; Lin Y; Sreekrishna K; Klukowska M; Huggins T; White DJ
Am J Dent; 2016 Dec; 29(6):328-332. PubMed ID: 29178720
[TBL] [Abstract][Full Text] [Related]
14. Different potency of bacterial antigens TLR2 and TLR4 ligands in stimulating mature mast cells to cysteinyl leukotriene synthesis.
Bąbolewska E; Witczak P; Pietrzak A; Brzezińska-Błaszczyk E
Microbiol Immunol; 2012 Mar; 56(3):183-90. PubMed ID: 22233438
[TBL] [Abstract][Full Text] [Related]
15. Distinct post-receptor alterations generate gene- and signal-selective adaptation and cross-adaptation of TLR4 and TLR2 in human leukocytes.
Li L; Jacinto R; Yoza B; McCall CE
J Endotoxin Res; 2003; 9(1):39-44. PubMed ID: 12691617
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of antimicrobial and lipoteichoic acid-sequestering properties in polyamine sulfonamides.
Warshakoon HJ; Burns MR; David SA
Antimicrob Agents Chemother; 2009 Jan; 53(1):57-62. PubMed ID: 18955537
[TBL] [Abstract][Full Text] [Related]
17. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved.
Schröder NW; Morath S; Alexander C; Hamann L; Hartung T; Zähringer U; Göbel UB; Weber JR; Schumann RR
J Biol Chem; 2003 May; 278(18):15587-94. PubMed ID: 12594207
[TBL] [Abstract][Full Text] [Related]
18. Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2.
Tancowny BP; Karpov V; Schleimer RP; Kulka M
Immunology; 2010 Oct; 131(2):220-30. PubMed ID: 20497485
[TBL] [Abstract][Full Text] [Related]
19. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
[TBL] [Abstract][Full Text] [Related]
20. Clinical effects of stannous fluoride dentifrice in reducing plaque microbial virulence III: Lipopolysaccharide and TLR2 reporter cell gene activation.
Xie S; Haught JC; Tansky CS; Klukowska M; Hu P; Ramsey DL; Circello B; Huggins TG; White DJ
Am J Dent; 2018 Aug; 31(4):215-224. PubMed ID: 30106539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
